Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030726

Director sold 12,286 shares at $43.57 ($535,301)

  • Director acquired 534 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Fust Matthew K Director 2018-05-14 Sale −12,286 $43.57 $535,301 19,820 D
Fust Matthew K Director 2018-05-15 Option exercise +534 20,354 D
Derivatives
Fust Matthew K Director 2018-05-15 Option exercise · Restricted Stock Units −534 0 D
Open-market sales · 12,286 sh · avg $43.57 · $535,301
Loading xslF345X03/doc4.xml…